The present invention relates to compounds of the formula (I) or pharmaceutically acceptable salts or hydrates thereof. The present invention further relates to processes for the preparation of the compounds of formula (I) and optical isomers and to use of the compounds of formula (I), isomers, pharmaceutically acceptable salts or hydrates thereof as medicaments, in particular as medicaments for the treatment and prevention of Hepatitis B.
本发明涉及式(I)化合物或其药学上可接受的盐或
水合物。本发明还涉及制备式(I)化合物及其光学异构体的方法,以及将式(I)化合物、异构体、药学上可接受的盐或
水合物作为药物的用途,特别是作为治疗和预防乙型肝炎的药物。